Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Naked Truth - Big Kahuna a Myth -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (71381)	10/23/1999 8:39:00 AM
From: re3	Read Replies (2) \| Respond to of 86076

msnbc.com

To: Ilaine who wrote (71381)	10/23/1999 2:01:00 PM
From: BGR	Respond to of 86076

CB, Indeed, US patents expire 20 years from the day of filing. As the drug development process goes, companies file for a product patent first and start phase 1 clinical trials next, the final drug being relased after the success of the phase 3 clinical trial. The first 3 phases together take upto 10 years, thus giving patent-protected profit life of approximately 10 years to a drug. When I see something erroneous posted in a public forum, I believe that the proper response is to post a correction supported by data/research. Apparently, you believe that the proper response is to walk away. Well, let's agree to disagree? -BGR.